Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease

Along with the increase in life expectancy, a significant increase of people suffering from neurodegenerative diseases (ND) has been noticed. The second most common ND, after Alzheimer’s disease, is Parkinson’s disease (PD), which manifests itself with a number of motor and non-motor symptoms that h...

Descripción completa

Detalles Bibliográficos
Autores principales: Królicka, Ewelina, Kieć-Kononowicz, Katarzyna, Łażewska, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317344/
https://www.ncbi.nlm.nih.gov/pubmed/35890146
http://dx.doi.org/10.3390/ph15070847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317344/
https://www.ncbi.nlm.nih.gov/pubmed/35890146
http://dx.doi.org/10.3390/ph15070847

Ejemplares similares